3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
85
Lymphoma, Follicular
53
Lymphoma
50
Lymphoma, Non-Hodgkin
47
Lymphoma, Mantle-Cell
45
Lymphoma, B-Cell, Marginal Zone
45
Leukemia, Lymphocytic, Chronic, B-Cell
40
Lymphoma, B-Cell
31
Recurrence
20
Burkitt Lymphoma
20
Waldenstrom Macroglobulinemia
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Neoplasms
16
Leukemia
11
Leukemia, Hairy Cell
7
Lymphoproliferative Disorders
5
Hodgkin Disease
5
Hematologic Neoplasms
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Hematologic Diseases
4
Dendritic Cell Sarcoma, Interdigitating
4
Neoplasm, Residual
3
Lymphoma, AIDS-Related
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia, Biphenotypic, Acute
3
Epstein-Barr Virus Infections
3
beta-Thalassemia
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Interventions
pembrolizumab
96
Carboplatin
67
Paclitaxel
56
Cyclophosphamide
40
Capecitabine
30
Specimen Handling
28
sacituzumab govitecan
25
130-nm albumin-bound paclitaxel
24
Gemcitabine
22
Magnetic Resonance Spectroscopy
21
Doxorubicin
20
olaparib
19
Taxes
19
Biopsy
19
Albumin-Bound Paclitaxel
19
Drug Therapy
16
atezolizumab
13
Nivolumab
13
toripalimab
12
Radiotherapy
12
Epirubicin
12
durvalumab
11
Docetaxel
10
Cisplatin
10
Bevacizumab
10
eribulin
9
fludarabine
8
Standard of Care
7
Radiation
7
Injections
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Rituximab
×
1 year
×
Clear all
No trials found.